Are insiders buying or selling Jade Biosciences, Inc. stock?

Based on the last 50 SEC Form 4 filings, Jade Biosciences, Inc. insiders made 2 open-market purchases and 5 open-market sales.

Where can I see Jade Biosciences, Inc. insider trading activity?

SEC Form 4 filings for Jade Biosciences, Inc. (JBIO) are publicly available on EDGAR and aggregated at form4api.com/companies/jbio.

Company profile

Jade Biosciences, Inc. Insider Trading

Name: Jade Biosciences, Inc. Insider Trading Data
Creator: Form4API
License: https://www.sec.gov/privacy.htm

JBIO

Every SEC Form 4 insider trading filing for Jade Biosciences, Inc. (JBIO) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange: Nasdaq
Sector: Pharmaceutical Preparations
CIK: 0001798749
Filings: 108
Insiders: 33
Last filing: 2026-06-25

SEC EDGAR ↗Yahoo Finance ↗Finviz ↗Stock Analysis ↗

Activity summary

No insider transactions in the last 30 days. The most recent was on June 25, 2026, when Eisner Mark bought 47,675 shares. 108 filings from 33 insiders are on record below.

Three year balance

Buy and sell value by quarter, Q2 23 to Q2 26. Jade Biosciences, Inc. insiders are net buyers across the period shown.

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $20.0M.

90 day insight

Over the last 90 days, Jade Biosciences, Inc. insiders bought $0 across 6 transactions with no open-market sales.

Most active insider: Eisner Mark with 1 transaction totaling $0.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

Date	Insider	Company	Type	Shares	Price	Value	1d	1w	1m	3m	6m
Jun 25, 2026	Eisner Mark	JBIO	Award	47,675	—	—	+0.5%	-3.2%	-10.5%	—	—
Jun 9, 2026	Dobmeier Eric	JBIO	Award	34,843	—	—	-4.6%	+4.6%	+32.7%	—	—
Jun 9, 2026	Lavelle Erin	JBIO	Award	34,843	—	—	-4.6%	+4.6%	+32.7%	—	—
Jun 9, 2026	Klein Lawrence Otto	JBIO	Award	34,843	—	—	-4.6%	+4.6%	+32.7%	—	—
Jun 9, 2026	Fairmount Funds Management LLC	JBIO	Award	34,843	—	—	-4.6%	+4.6%	+32.7%	—	—

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=JBIO" \
  -H "X-Api-Key: $KEY"

Get a key

Top insiders

By total value filed.

Fairmount Funds Management LLCDirector2 filings+$20.0M

Ra Capital Management, L.p.1 filing+$1.5M

Verwijs MarinusSENIOR VICE PRESIDENT, CMC2 filings−$110K

Eldridge George ASEE REMARKS2 filings−$343K

Gillies HunterCHIEF MEDICAL OFFICER4 filings−$218K

Institutional Ownership

Top 13F-HR holders of Jade Biosciences, Inc. as of 2026-06-30

↓ decreasing

Total reported AUM

$198.1M

QoQ change

-71.5%

Reporting period

2026-06-30

State Street Corp

CIK 0000093751

$51.9M

2.3M shares

Remedium Capital Partners, LLC

CIK 0002104501

$35.1M

1.6M shares

BlackRock, Inc.

CIK 0002012383

$30.6M

1.4M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →